Home Novamind

Novamind

acquired
IPO
Psychedelic Drug Supplier
Basic
Enterprise Profile

Basic Information

Novamind is a leading supplier of psychedelic drugs. We specialize in holistic psychiatry, conduct state-of-the-art diagnostic investigations, and offer personalized treatment plans that utilize a range of innovative therapeutic approaches for our clients. In light of the U.S. FDA's approval of MDMA and psilocybin-assisted psychotherapy, Novamind is developing a national network of clinics specializing in psychedelic medicine.
Novamind Inc.
Toronto,Ontario,Canada
less than 15 people
May 22, 2019
info@novamind.ca

Enterprise Profile

Industrial Sector
New Drug Development Independent Medical Ancillary Services
Concept
Department of Psychiatry Health Management
Application Scenarios
Consumer Healthcare Innovative Drugs